These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7622436)

  • 41. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors.
    Fancelli D; Chiari A; Cozzi P; Lovisolo P; Severino D; Ghiselli G
    J Enzyme Inhib; 1994; 8(3):159-72. PubMed ID: 7539485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5,6-Diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors.
    Giovannoni MP; Piaz VD; Kwon BM; Kim MK; Kim YK; Toma L; Barlocco D; Bernini F; Canavesi M
    J Med Chem; 2001 Nov; 44(24):4292-5. PubMed ID: 11708931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic and ACAT-inhibitory sesquiterpene lactones from the root of Ixeris dentata forma albiflora.
    Ahn EM; Bang MH; Song MC; Park MH; Kim HY; Kwon BM; Baek NI
    Arch Pharm Res; 2006 Nov; 29(11):937-41. PubMed ID: 17146959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Maduskuie TP; Wilde RG; Billheimer JT; Cromley DA; Germain S; Gillies PJ; Higley CA; Johnson AL; Pennev P; Shimshick EJ
    J Med Chem; 1995 Mar; 38(7):1067-83. PubMed ID: 7707310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305.
    Tomoda H; Nishida H; Huang XH; Masuma R; Kim YK; Omura S
    J Antibiot (Tokyo); 1992 Aug; 45(8):1207-15. PubMed ID: 1399840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total synthesis of alpha-pyrone meroterpenoids, novel bioactive microbial metabolites.
    Sunazuka T; Omura S
    Chem Rev; 2005 Dec; 105(12):4559-80. PubMed ID: 16351054
    [No Abstract]   [Full Text] [Related]  

  • 48. Structure-activity relationships study of pyripyropenes: reversal of cancer cell multidrug resistance.
    Obata R; Sunazuka T; Harigaya Y; Hayashi M; Rho MC; Tomoda H; Omura S
    J Antibiot (Tokyo); 2000 Apr; 53(4):422-5. PubMed ID: 10866225
    [No Abstract]   [Full Text] [Related]  

  • 49. Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
    Ohishi K; Aiyama R; Hatano H; Yoshida Y; Wada Y; Yokoi W; Sawada H; Watanabe T; Yokokura T
    Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):830-9. PubMed ID: 11456087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acaterin, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Pseudomonas sp. A92.
    Naganuma S; Sakai K; Hasumi K; Endo A
    J Antibiot (Tokyo); 1992 Aug; 45(8):1216-21. PubMed ID: 1399841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.
    Kinnunen PM; DeMichele A; Lange LG
    Biochemistry; 1988 Sep; 27(19):7344-50. PubMed ID: 3207680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. Structure-activity relationships of novel N-(4-oxochroman-8-yl)amides.
    Kataoka K; Shiota T; Takeyasu T; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
    J Med Chem; 1995 Aug; 38(16):3174-86. PubMed ID: 7636880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, X-ray crystal structure, and biological activity of FR186054, a novel, potent, orally active inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) bearing a pyrazole ring.
    Tanaka A; Terasawa T; Hagihara H; Kinoshita T; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    Bioorg Med Chem Lett; 1998 Jan; 8(1):81-6. PubMed ID: 9871633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purpactins, new inhibitors of acyl-CoA:cholesterol acyltransferase produced by Penicillium purpurogenum. III. Chemical modification of purpactin A.
    Nishida H; Tomoda H; Cao J; Araki S; Okuda S; Omura S
    J Antibiot (Tokyo); 1991 Feb; 44(2):152-9. PubMed ID: 2010355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
    Harte RA; Yeaman SJ; Jackson B; Suckling KE
    Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pheophorbide A-methyl ester, Acyl-CoA: cholesterol acyltransferase inhibitor from Diospyros kaki.
    Rho MC; Chung MY; Song HY; Kwon OE; Lee SW; Baek JA; Jeune KH; Kim K; Lee HS; Kim YK
    Arch Pharm Res; 2003 Sep; 26(9):716-8. PubMed ID: 14560918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro metabolism of pyripyropene A and ACAT inhibitory activity of its metabolites.
    Matsuda D; Ohshiro T; Ohtawa M; Yamazaki H; Nagamitsu T; Tomoda H
    J Antibiot (Tokyo); 2015 Jan; 68(1):27-34. PubMed ID: 25005817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic conversion of ACAT inhibitor to acetylcholinesterase inhibitor.
    Obata R; Sunazuka T; Otoguro K; Tomoda H; Harigaya Y; Omura S
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1315-6. PubMed ID: 10890154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.